|

Mozobil (TM) Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • National Institute of Allergy and Infectious Diseases (NIAID)1

Indications

  • Myelokathexis1
  • Leukopenia1
  • Neutropenia1
  • Warts1
  • Infections1

Bethesda, Maryland1 trial

A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

National Institutes of Health Clinical Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.